Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand [0.03%]
利用EQ-5D-5L调查疾病修正疗法对新西兰多发性硬化症患者生活质量的影响政策
Suzi Claflin,Julie A Campbell,Richard Norman et al.
Suzi Claflin et al.
Background: Health state utilities (HSU) are a health-related quality-of-life (HRQoL) input for cost-utility analyses used for resource allocation decisions, including medication reimbursement. New Zealand (NZ) guidelines...
Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review [0.03%]
矫正：结直肠癌治疗的终身直接医疗费用：一项系统评价
Nazim Bhimani,Geoffrey Y M Wong,Charles Molloy et al.
Nazim Bhimani et al.
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries [0.03%]
在欧洲15个国家中对流感样症状患者在基层医疗中加用奥司他韦的成本效益分析：随机对照ALIC4E试验的经济学评价
Xiao Li,Joke Bilcke,Alike W van der Velden et al.
Xiao Li et al.
Background: Oseltamivir is usually not often prescribed (or reimbursed) for non-high-risk patients consulting for influenza-like-illness (ILI) in primary care in Europe. We aimed to evaluate the cost-effectiveness of addi...
Do mobile hospital teams in residential aged care facilities increase health care efficiency: an evaluation of French residential care policy [0.03%]
流动医院团队能否提高护理机构的卫生系统效率：一项关于法国居住型养老院政策的评估研究
Anne Penneau
Anne Penneau
Context: Patients in residential aged care facilities (RACF) are frequently admitted to hospital since the RACF often lack adequate medical resources. Different economic agents, whose missions and funding may conflict, pr...
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK [0.03%]
周一次剂量1毫克索马鲁肽与英国的3毫克和4.5毫克杜拉鲁肽的长期成本效益分析
Adie Viljoen,Barrie Chubb,Samuel J P Malkin et al.
Adie Viljoen et al.
Aims: Once-weekly semaglutide and dulaglutide represent two highly efficacious treatment options for type 2 diabetes. A recent indirect treatment comparison (ITC) has associated semaglutide 1 mg with similar and greater i...
An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals [0.03%]
德國醫院多種心血管終點的統計學整合方法
Angela Meggiolaro,Carl Rudolf Blankart,Tom Stargardt et al.
Angela Meggiolaro et al.
Objective: Development of an aggregate quality index to evaluate hospital performance in cardiovascular events treatment. Methods: We a...
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients [0.03%]
胃癌患者的EQ-5D-5L和EORTC QLU-C10D效用值的比较研究
Chen-Wei Pan,Jun-Yi He,Yan-Bo Zhu et al.
Chen-Wei Pan et al.
Background: To compare measurement properties of the utility scores derived from various country-specific value sets of EQ-5D-5L (5L) and EORTC QLU-C10D (10D) in gastric cancer patient. ...
Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment [0.03%]
采用离散选择实验估算避免食源性疾病后果的支付意愿
Kathleen Manipis,Brendan Mulhern,Philip Haywood et al.
Kathleen Manipis et al.
Lost productivity is one of the largest costs associated with foodborne illness (FBI); however, the methods used to estimate lost productivity are often criticised for overestimating the actual burden of illness. A discrete choice experimen...
Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study [0.03%]
肥胖和代谢状况与增加的卫生资源和药物使用及成本有关：一项基于芬兰人口的研究
Aino Vesikansa,Juha Mehtälä,Katja Mutanen et al.
Aino Vesikansa et al.
Aim: To characterize healthcare resource (HCRU) and medication use and associated costs in individuals with obesity compared with individuals with normal weight or overweight in a population-based cohort of Finnish adults...